The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126469241 12646924 1 I 20160802 20160812 20160812 EXP JP-MLMSERVICE-20160727-0361109-1 JP-ACCORD-043109 ACCORD HISHIDA T, YOSHIDA J, AOKAGE K, NAGAI K, TSUBOI M. LONG-TERM OUTCOME OF SURGICAL RESECTION FOR RESIDUAL OR REGROWN ADVANCED NON-SMALL CELL LUNG CARCINOMAS FOLLOWING EGFR-TKI TREATMENT: REPORT OF FOUR CASES.GENERAL THORACIC AND CARDIOVASCULAR SURGERY. 2016; 64(7):429-433. 58.00 YR F Y 0.00000 20160812 MD JP JP

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126469241 12646924 1 PS PACLITAXEL/PACLITAXEL LIPOSOME PACLITAXEL 1 TWO CYCLES 75436
126469241 12646924 2 SS VINORELBINE VINORELBINEVINORELBINE TARTRATE 1 TWO CYCLES 0
126469241 12646924 3 SS CISPLATIN. CISPLATIN 1 TWO CYCLES 0
126469241 12646924 4 SS CARBOPLATIN. CARBOPLATIN 1 TWO CYCLES 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126469241 12646924 1 Lung adenocarcinoma stage III
126469241 12646924 2 Lung adenocarcinoma stage III
126469241 12646924 3 Lung adenocarcinoma stage III
126469241 12646924 4 Lung adenocarcinoma stage III

Outcome of event

Event ID CASEID OUTC COD
126469241 12646924 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
126469241 12646924 Drug ineffective

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found